Skip to content

OptimizeRx OPRX Share Repurchase Authorization Limit

Share Repurchase Authorization Limit at other companies

Spok Holdings logo
Spok HoldingsSPOK
$10M
Doximity logo
DoximityDOCS
$83M-81.6%
Veeva Systems logo
Veeva SystemsVEEV

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept srt:StockRepurchaseProgramAuthorizedAmount1.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's share repurchase authorization limit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's share repurchase authorization limit?
OptimizeRx (OPRX) reported share repurchase authorization limit of $10M in Q1 2024.
What does share repurchase authorization limit mean?
This represents the total dollar value or share count that the board of directors has authorized the company to spend on repurchasing its own common stock from the open market. It serves as a signal of management's confidence in the company's valuation and its commitment to returning capital to shareholders. This limit is an authorization, not an obligation to spend.